โ Best Covered Calls
/ VRTX
VRTX Covered Call Analysis: Proceed With Caution Weak ยท 35/100
Vertex Pharmaceuticals Inc (Healthcare) ยท $515.02 ยท
Analysis generated Nov 20, 2026 ยท
Data as of market close Nov 20
This strategy is NOT recommended for VRTX right now
Score 35/100. The technical signals do not support selling covered calls on VRTX at this time.
IV -58% vs avg โ premiums below average, less income. MACD bearish โ stock may keep falling (risk). TTM Squeeze ON โ breakout imminent, risky for capped strategies.
Check back when conditions improve, or consider a different strategy.
Quick Take
VRTX is trading at $515.02 with RSI at 43 (neutral territory). Options IV is at 33% โ 58% below its 30-day average of 79%. Neither RSI nor IV strongly favor selling calls right now. Consider waiting for better conditions or using a different strategy.
Technical Signals
RSI (14)
43
IV Today
33.1%
IV vs 30d Avg
-58%
MACD
bearish
ADX
11
MFI
48
The Setup
VRTX Covered Call
LONG STOCK
100 shares @ $515.02
SHORT CALL
$560 Jan '27 ยท $24.0/sh
Net Cost
$49,102
Max Profit
+$6,898
Break-even
$491.02
Projected P&L at Target
+$6,520
(13.3%)
P&L at Expiry
P&L Scenarios
What happens at different VRTX prices by expiry:
| VRTX Price | Today | +3d (Nov 24) | +7d (Nov 28) | Dec 9 | Dec 27 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $412 (-20%) | -$8,144 | -$8,113 | -$8,074 | -$7,984 | -$7,906 | -$7,900 |
| $438 (-15%) | -$5,824 | -$5,774 | -$5,709 | -$5,545 | -$5,358 | -$5,325 |
| $464 (-10%) | -$3,667 | -$3,595 | -$3,500 | -$3,242 | -$2,873 | -$2,750 |
| $489 (-5%) | -$1,715 | -$1,622 | -$1,496 | -$1,138 | -$535 | -$175 |
| $505 (-2%) | -$656 | -$552 | -$409 | +$4 | +$752 | +$1,370 |
| $515 (0%) โ now | -$0 | +$112 | +$264 | +$709 | +$1,547 | +$2,400 |
| $525 (+2%) | +$616 | +$733 | +$894 | +$1,367 | +$2,283 | +$3,430 |
| $541 (+5%) | +$1,464 | +$1,588 | +$1,758 | +$2,263 | +$3,270 | +$4,975 |
| $556 (+8%) โ target | +$2,221 | +$2,349 | +$2,525 | +$3,050 | +$4,107 | +$6,520 |
| $567 (+10%) | +$2,677 | +$2,806 | +$2,984 | +$3,514 | +$4,581 | +$6,898 |
| $592 (+15%) | +$3,654 | +$3,783 | +$3,958 | +$4,478 | +$5,494 | +$6,898 |
| $618 (+20%) | +$4,422 | +$4,543 | +$4,709 | +$5,190 | +$6,076 | +$6,898 |
Why This Strategy, Why Now
- RSI at 43
- IV -58% vs avg โ premiums below average, less income
- MACD bearish โ stock may keep falling (risk)
- ADX at 11 โ range-bound, perfect for selling calls
- TTM Squeeze ON โ breakout imminent, risky for capped strategies
Key Risks
TTM Squeeze is ON โ a volatility breakout may be imminent. If the breakout is to the upside, your short call will be tested quickly.